$AVR News

Anteris Technologies Global To Offer Up To $250M Of Common Stock Through TD Cowen

Barclays Maintains Overweight on Anteris Technologies Glb, Raises Price Target to $18

Anteris Technologies Glb Q1 EPS $(0.28) Misses $(0.27) Estimate, Sales $494.000K Miss $766.667K Estimate

Anteris Technologies Global To Discontinue Development Contributions Under Agreement With v2vmedtech; Required To Pay $400,000 Break Fee To v2vmedtech; Expects No Material Adverse Effect From Agreement Termination

Anteris Technologies Secures CMS Reimbursement Supporting U.S. Site Activation for PARADIGM Trial

Anteris secures US Medicare coverage for PARADIGM Trial as DurAVR study advances

Anteris Technologies Receives U.S. Medicare Reimbursement Eligibility For Its Global Pivotal PARADIGM Trial Under A CMS National Coverage Policy

Cantor Fitzgerald Reiterates Overweight on Anteris Technologies Glb, Maintains $15 Price Target

Anteris Technologies Global CEO Touts DurAVR Redesign, Durability Claims and TAVR Market Strategy

Cantor Fitzgerald Assumes Anteris Technologies Glb at Overweight, Announces Price Target of $15

Wells Fargo Initiates Coverage On Anteris Technologies Glb with Overweight Rating, Announces Price Target of $16

Anteris reports US$77.8m 2025 net operating cash outflow as PARADIGM trial gets underway

Anteris Reports 2025 Financial Results and Provides Corporate Update

Anteris Technologies Glb Q4 EPS $(0.75) Misses $(0.58) Estimate, Sales $310.000K Beat $200.000K Estimate

Anteris to Present at Healthcare Investor Conferences TD Cowen and Barclays

Retail investors who hold 25% of Anteris Technologies Global Corp. (ASX:AVR) gained 41%, institutions profited as well

Anteris Technologies Global Completes $90M Investment From Medtronic

Anteris Technologies announces $200M public offering to fund clinical growth

Anteris Technologies Global shares are trading higher. The company announced it priced its $200 million public offering of 34.8 million shares at $5.75 per share.

Anteris Technologies Global shares are trading higher. The company announced it priced its $200 million public offering of 34.8 million shares at $5.75 per share.